» Authors » Tom D J Smilde

Tom D J Smilde

Explore the profile of Tom D J Smilde including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 961
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Allach Y, Barry-Loncq de Jong M, Clephas P, van Gent M, Brunner-La Rocca H, Szymanski M, et al.
Eur J Heart Fail . 2024 Jun; 26(8):1736-1744. PMID: 38825743
Aims: Heart failure (HF), a global pandemic affecting millions of individuals, calls for adequate predictive guidance for improved therapy. Congestion, a key factor in HF-related hospitalizations, further underscores the need...
2.
Clephas P, Zwartkruis V, Malgie J, van Gent M, Brunner-La Rocca H, Szymanski M, et al.
Eur Heart J . 2024 May; 45(32):2954-2964. PMID: 38733175
Background And Aims: In patients with chronic heart failure (HF), the MONITOR-HF trial demonstrated the efficacy of pulmonary artery (PA)-guided HF therapy over standard of care in improving quality of...
3.
Damman K, Beusekamp J, Boorsma E, Swart H, Smilde T, Elvan A, et al.
Eur J Heart Fail . 2020 Jan; 22(4):713-722. PMID: 31912605
Aims: Inhibition of sodium-glucose co-transporter 2 (SGLT2) reduces the risk of death and heart failure (HF) admissions in patients with chronic HF. However, safety and clinical efficacy of SGLT2 inhibitors...
4.
Damman K, van der Harst P, Smilde T, Voors A, Navis G, Van Veldhuisen D, et al.
Heart . 2011 Nov; 98(4):319-24. PMID: 22038544
Background: Estimates of glomerular filtration rate (GFR), including creatinine and creatinine based formulae, are inaccurate in extremes of GFR and substantially biased in patients with chronic heart failure (CHF). Objective:...
5.
Damman K, Van Veldhuisen D, Navis G, Vaidya V, Smilde T, Westenbrink B, et al.
Heart . 2010 Jul; 96(16):1297-302. PMID: 20659949
Background: The prognostic impact of reduced glomerular filtration rate (GFR) in chronic heart failure (CHF) is increasingly recognised, but little is known about tubular damage in these patients. Objective: To...
6.
Smilde T, Van Veldhuisen D, van den Berg M
Clin Res Cardiol . 2009 Feb; 98(4):233-9. PMID: 19219394
Background: In contrast to patients with moderate to severe chronic heart failure (CHF), data regarding long-term outcome in patients with mild CHF are scarce. We examined the place of Holter...
7.
Smilde T, Damman K, van der Harst P, Navis G, Westenbrink B, Voors A, et al.
Clin Res Cardiol . 2008 Nov; 98(2):121-9. PMID: 18979056
Background: Reduced glomerular filtration rate (GFR) is strongly associated with reduced survival in patients with chronic heart failure (CHF). Our aim was to determine different pathophysiologic markers that are associated...
8.
Hartog J, Voors A, Schalkwijk C, Scheijen J, Smilde T, Damman K, et al.
Eur Heart J . 2007 Nov; 28(23):2879-85. PMID: 17986469
Aims: Advanced glycation end-products (AGEs) have been proposed as a novel factor involved in the development and progression of chronic heart failure (CHF). We aimed to determine whether plasma levels...
9.
Damman K, Navis G, Voors A, Asselbergs F, Smilde T, Cleland J, et al.
J Card Fail . 2007 Oct; 13(8):599-608. PMID: 17923350
Background: Renal impairment is associated with increased mortality in heart failure (HF). Recently, reports suggest that worsening renal function (WRF) is another predictor of clinical outcome in HF. The present...
10.
Smilde T, Zuurman M, Hillege H, Van Veldhuisen D, van Gilst W, van der Steege G, et al.
Am J Hypertens . 2007 Oct; 20(10):1097-103. PMID: 17903694
Background: The association of renin-angiotensin system (RAS) polymorphisms and left-ventricular hypertrophy (LVH) may depend on the presence of risk factors for LVH, such as renal dysfunction. We studied whether renal...